American Board of Psychiatry and Neurology

PROCESSA PHARMACEUTICALS ANNOUNCES FORMATION OF ITS MEDICAL AND SCIENTIFIC ADVISORY BOARD

Retrieved on: 
Thursday, March 5, 2020

John Devane and Dr. James Shipleyto itsMedical and Scientific Advisory Board.

Key Points: 
  • John Devane and Dr. James Shipleyto itsMedical and Scientific Advisory Board.
  • We are pleased to welcome the first two members of our newly formed Medical and Scientific Advisory Board, said Dr. David Young, CEO of Processa.
  • Previously, Dr. Devane was Chief Scientific Officer (CSO) with Horizon PharmaIreland Ltd.and from 2012-2014 served as CSO to Vidara Therapeutics Research Ltd.
  • Dr. Shipley is board certified by both the American Board of Psychiatry & Neurology and the American Board of Sleep Medicine.

SOC Telemed Neurology Council Highlights Accomplishments In Inaugural Year

Retrieved on: 
Tuesday, January 28, 2020

RESTON, Va., Jan. 28, 2020 /PRNewswire/ --SOC Telemed (SOC), the leader in acute care telemedicine, today commemorates accomplishments from the SOC Neurology Leadership Council's inaugural year.

Key Points: 
  • RESTON, Va., Jan. 28, 2020 /PRNewswire/ --SOC Telemed (SOC), the leader in acute care telemedicine, today commemorates accomplishments from the SOC Neurology Leadership Council's inaugural year.
  • Heading into its second year, the Leadership Council identified the following inaugural-year accomplishments:
    Concurrent with its accomplishments, the Neurology Leadership Council is pleased to announce that Dr. Eric Anderson, M.D., Ph.D., has stepped into the role of Chair.
  • Dr. Morton is board-certified in Neurology with a subspecialty certification in Vascular Neurology by the American Board of Psychiatry and Neurology.
  • SOC Telemed (SOC) is the largest national provider of telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations.

Pfenex Announces Appointment of New Board Member, Lorianne Masuoka, M.D.

Retrieved on: 
Thursday, August 8, 2019

We are pleased to welcome Dr. Masuoka to the Pfenex Board of Directors.

Key Points: 
  • We are pleased to welcome Dr. Masuoka to the Pfenex Board of Directors.
  • Her appointment further aligns the Board with the Companys strategy to build a new R&D capability.
  • I am honored to join the Pfenex Board and have an opportunity to work with my fellow board members and the management team at this ever-important point in the Companys history, stated Dr. Masuoka.
  • She completed her epilepsy fellowship at Yale University and is board certified by the American Board of Psychiatry and Neurology.

TrueLearn Launches New AAN RITE and ABPN Certification Exam SmartBanks for Neurology Residents

Retrieved on: 
Thursday, June 6, 2019

After evaluating the field of Neurology, TrueLearn determined that these residents were in need of more test prep materials for both the AAN RITE and the ABPN Board Certification Exam.

Key Points: 
  • After evaluating the field of Neurology, TrueLearn determined that these residents were in need of more test prep materials for both the AAN RITE and the ABPN Board Certification Exam.
  • Acknowledging the importance of the AAN RITE as a performance indicator for the final board exam (ABPN Board Certification Exam), TrueLearn determined that the AAN RITE SmartBank following the official American Academy of Neurology (AAN) blueprint was necessary for long-term success.
  • The American Academy of Neurology (AAN) conducted a study analyzing the relationship between AAN RITE performance and subsequent ABPN Board Certification Exam performance.
  • For more information about TrueLearn, the AAN RITE SmartBank, or the ABPN Board Certification Exam SmartBank, call 866-475-4777 or visit http://www.truelearn.com/neurology .

Order 66 Labs Announces Inaugural Scientific Advisory Board Members

Retrieved on: 
Thursday, May 31, 2018

LAS VEGAS, May 31, 2018 /PRNewswire/ --After consulting informally for months with academic and industry leaders in the fields of Addiction Medicine, Digital Health and Virtual Reality, Order 66 Labs is pleased to announce the formation of a scientific advisory board and two inaugural members.

Key Points: 
  • LAS VEGAS, May 31, 2018 /PRNewswire/ --After consulting informally for months with academic and industry leaders in the fields of Addiction Medicine, Digital Health and Virtual Reality, Order 66 Labs is pleased to announce the formation of a scientific advisory board and two inaugural members.
  • Order 66 Labs founder, Dr. Matthew Prekupec, explained:"Drs.
  • She is a diplomate of the American Board of Psychiatry and Neurology, and of the American Board of Addiction Medicine.
  • About Order 66 Labs: Order 66 Labs is an early-stage private company dedicated to improving the lives of people affected by addiction using digital health technologies.